Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Annika, Loftenius"'
Autor:
Nina Eissler, Renske Altena, Ali Alhuseinalkhudhur, Olga Bragina, Joachim Feldwisch, Guido Wuerth, Annika Loftenius, Nikolai Brun, Rimma Axelsson, Vladimir Tolmachev, Jens Sörensen, Fredrik Y. Frejd
Publikováno v:
Biomedicines, Vol 12, Iss 5, p 1088 (2024)
Human epidermal growth factor receptor 2 (HER2) is a major prognostic and predictive marker overexpressed in 15–20% of breast cancers. The diagnostic reference standard for selecting patients for HER2-targeted therapy is based on the analysis of tu
Externí odkaz:
https://doaj.org/article/fca4871fc0e24c1fb9ada3331b3daf97
Autor:
Yongsheng Liu, Anzhelika Vorobyeva, Anna Orlova, Mark W. Konijnenberg, Tianqi Xu, Olga Bragina, Annika Loftenius, Erica Rosander, Fredrik Y. Frejd, Vladimir Tolmachev
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 1092 (2022)
HER2-targeted radionuclide therapy might be helpful for the treatment of breast, gastric, and ovarian cancers which have developed resistance to antibody and antibody-drug conjugate-based therapies despite preserved high HER2-expression. Affibody mol
Externí odkaz:
https://doaj.org/article/da16e0189db8472da3f51e8a4d57cead
Autor:
Yongsheng Liu, Anzhelika Vorobyeva, Tianqi Xu, Anna Orlova, Annika Loftenius, Theresa Bengtsson, Per Jonasson, Vladimir Tolmachev, Fredrik Y. Frejd
Publikováno v:
Pharmaceutics, Vol 13, Iss 6, p 839 (2021)
Radiolabeled Affibody-based targeting agent 177Lu-ABY-027, a fusion of an anti-HER2 Affibody molecule with albumin binding domain (ABD) site-specifically labeled at the C-terminus, has demonstrated a promising biodistribution profile in mice; binding
Externí odkaz:
https://doaj.org/article/00f911f282414140bdb24d31c317d2e0
Autor:
Yongsheng Liu, Tianqi Xu, Anzhelika Vorobyeva, Annika Loftenius, Vitalina Bodenko, Anna Orlova, Fredrik Y. Frejd, Vladimir Tolmachev
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2409
Affibody molecules are artificial proteins that can recognize cancer-related molecular abnormalities in the living body. Clinical studies demonstrated that Affibody molecules can be successfully used for radionuclide diagnostics. Targeted radionuclid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b4ce15d7b3d9b9b3fd53bd4749d0eab
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-502522
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-502522
Autor:
Yongsheng Liu, Anzhelika Vorobyeva, Anna Orlova, Mark Konijnenberg, Tianqi Xu, Olga Bragina, Annika Loftenius, Erica Rosander, Fredrik Frejd, Vladimir Tolmachev
Publikováno v:
Nuclear Medicine and Biology. :S27
Autor:
Maryam, Oroujeni, Sara S, Rinne, Anzhelika, Vorobyeva, Annika, Loftenius, Joachim, Feldwisch, Per, Jonasson, Vladimir, Chernov, Anna, Orlova, Fredrik Y, Frejd, Vladimir, Tolmachev
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2770, p 2770 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 5
International Journal of Molecular Sciences
Volume 22
Issue 5
Radionuclide imaging of HER2 expression in tumours may enable stratification of patients with breast, ovarian, and gastroesophageal cancers for HER2-targeting therapies. A first-generation HER2-binding affibody molecule [99mTc]Tc-ZHER2:V2 demonstrate
Publikováno v:
Clinical Nutrition. 15:75-79
Insulin sensitivity was determined before and after elective surgery in 31 otherwise healthy patients undergoing elective surgery for open cholecystectomy (n = 24) or inguinal hernia repair (n = 7) and compared with concomitant plasma concentrations
Publikováno v:
Annals of tropical medicine and parasitology. 84(2)
Antibody responses in schistosomiasis haematobium were studied in relation to age and infection intensity in Somalia. The area is highly endemic for Schistosoma haematobium but free of S. mansoni. Antibodies of the IgG class against particulate antig